Answer:
Periodic selection.
Explanation:
Some bacterial strain has the ability to develop the resistance against the particular drug. This helps the bacteria to survive against the adverse environmental conditions.
The periodic selection may be defined as the natural selection that selects some strains of the bacteria that can survive in the particular environment. The periodic selection also favors the adaptive mutation that might occur due to the recombination in bacteria and removes the non selective species. The information given in the question provides the example of periodic selection.
Thus, the answer is periodic selection.
Sickle cell anemia is persistent in the tropics because those with sickle cell anemia cant contract the malaria virus because of the shape of their blood cells, and this is advantageous in the tropics where there are more malaria cases. So those with sickle cell anemia live to pass on their genes.
This description is unspecific and is confusing...
The nose has different functions mainly for inhalation of oxygen and exhalation of carbon dioxide which is called the respiration process or gas exchange. As a sensory organ, the nose has also another function which is olfaction, the ability to smell.
Olfaction in a biopsychological term, is the process by which sensory information recognized by the nasal receptors are transduced in a understandable and recognizable stimulus or rather perception, in simplest term is to smell.
Therefore, nasal receptors are the structures that send messages to the facial nerve which is responsible for sending the information to the brain for it to be perceived and acknowledge.
Answer:
B
The second student has not yet seen the same sunrise.
Explanation:
Because as the day goes on, the sunlight shines on places without light as the earth is rotating.
Blood coagulation can be triggered by vascular devices including stents, hemodialyzers, and membrane oxygenators; as a result, systemic anticoagulants are frequently needed to prevent specific intravascular thrombotic/embolic events or extracorporeal device failure. Vascular device surface-initiated thrombus development has been demonstrated to be significantly influenced by coagulation factor (F)XII of the contact activation system. Targeting the contact activation system shows promise as a substantially safer method than conventional antithrombotic for avoiding vascular device-associated thrombosis because FXII is not required for hemostasis. Create and describe anti-FXII monoclonal antibodies that block the activation or activity of the enzyme. Methods: In FXII-deficient animals, monoclonal antibodies against FXII were produced, and their binding and anticoagulant abilities were examined in purified plasma systems, whole blood flow-based tests, and an in vitro experiment.
thrombus development caused by a vascular device in a living non-human primate animal. Results: Over 400 candidates were selected from an FXII antibody screen and tested in binding and clotting experiments. Six inhibitor antibodies and one non-inhibitor antibody were chosen for functional test evaluation. The most effective inhibitory antibody, 1B2, has been shown to lengthen clotting durations, inhibit fibrin development on collagen under shear, and inhibit platelet deposition and fibrin formation in an extracorporeal membrane oxygenator used in a non-human primate. Conclusion: Selective contact activation inhibitors have the potential to be helpful research tools as well as secure and efficient thrombosis inhibitors for vascular devices.
Learn more about anticoagulant brainly.com/question/14834794
#SPJ4
